25 related articles for article (PubMed ID: 3251189)
1. [Estimation of frequency, population doses and stochastic risks in medical uses of radiopharmaceuticals in Japan, 1982. 3. Population doses and risk estimates].
Maruyama T; Yamaguchi H; Noda Y; Kumamoto Y; Iwai K; Nishizawa K
Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Dec; 48(12):1544-52. PubMed ID: 3251190
[No Abstract] [Full Text] [Related]
2. [Estimation of frequency, population doses and stochastic risks in medical uses of radiopharmaceuticals in Japan, 1982. 1. The number of medical examinations using radiopharmaceuticals].
Maruyama T; Noda Y; Kumamoto Y; Nishizawa K; Iwai K
Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Jul; 48(7):911-20. PubMed ID: 3194183
[No Abstract] [Full Text] [Related]
3. [Estimation of population doses from medical uses of radiopharmaceuticals in Japan, 1977. I. The number of medical examinations using radiopharmaceuticals (author's transl)].
Hashizume T; Maruyama T; Tateno Y; Yamaguchi H; Nishizawa K
Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Mar; 39(3):267-76. PubMed ID: 440920
[No Abstract] [Full Text] [Related]
4. [Estimation of stochastic risk from computed tomographic examinations in Japan, 1979. 3. Estimation of population doses and stochastic risks (author's transl)].
Nishizawa K; Maruyama T; Iwata T; Furuya Y; Hashizume T
Nihon Igaku Hoshasen Gakkai Zasshi; 1981 May; 41(5):436-41. PubMed ID: 7301533
[No Abstract] [Full Text] [Related]
5. [Estimation of population doses from medical uses of radiopharmaceuticals in Japan, 1977. 2. Estimation of genetically significant dose, per caput mean bone marrow dose and leukemia significant dose (author's transl)].
Hashizume T; Maruyama T; Yamaguchi H; Nishizawa K; Tateno Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Jul; 39(7):747-60. PubMed ID: 492934
[No Abstract] [Full Text] [Related]
6. [Estimation of frequency, population doses and stochastic risks in medical uses of radiopharmaceuticals in Japan, 1982. 2. Determination of organ or tissue doses and effective dose equivalents].
Maruyama T; Yamaguchi H; Noda Y; Kumamoto Y; Iwai K; Nishizawa K
Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Dec; 48(12):1536-43. PubMed ID: 3251189
[No Abstract] [Full Text] [Related]
7. Biokinetic and dosimetric modelling in the estimation of radiation risks from internal emitters.
Harrison J
J Radiol Prot; 2009 Jun; 29(2A):A81-A105. PubMed ID: 19454809
[TBL] [Abstract][Full Text] [Related]
8. Radiation doses and risks from internal emitters.
Harrison J; Day P
J Radiol Prot; 2008 Jun; 28(2):137-59. PubMed ID: 18495991
[TBL] [Abstract][Full Text] [Related]
9. [Basis of radiation protection].
Roth J; Schweizer P; Gückel C
Schweiz Med Wochenschr; 1996 Jun; 126(26):1157-71. PubMed ID: 8711464
[TBL] [Abstract][Full Text] [Related]
10. [Current topics in radiopharmaceuticals in Japan. (I). Radiopharmaceuticals for medical use].
Terao T
Radioisotopes; 1984 Jan; 33(1):37-41. PubMed ID: 6377397
[No Abstract] [Full Text] [Related]
11. Internal radionuclide radiation dosimetry: a review of basic concepts and recent developments.
Zanzonico PB
J Nucl Med; 2000 Feb; 41(2):297-308. PubMed ID: 10688115
[TBL] [Abstract][Full Text] [Related]
12. A survey of the benefits and risks in the practice of radiology.
Payne JT; Loken MK
CRC Crit Rev Clin Radiol Nucl Med; 1975 Jul; 6(3):425-39. PubMed ID: 1097189
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
